음식 알레르기 진단 및 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Food Allergy Diagnostics And Therapeutics Market size is expected to reach USD 20.85 Billion in 2034 from USD 10.01 Billion (2025) growing at a CAGR of 8.49% during 2026-2034.

The global food allergy diagnostics and therapeutics market is expanding rapidly due to the increasing prevalence of food allergies worldwide. Allergic reactions to foods such as peanuts, milk, eggs, and shellfish have become more common, particularly among children. This growing health concern is driving demand for accurate diagnostic tests and effective therapeutic solutions to manage and prevent severe allergic reactions.

Advancements in diagnostic technologies are playing a crucial role in improving allergy detection. Blood tests, skin prick tests, and molecular diagnostic tools are helping healthcare professionals identify specific allergens more accurately. At the same time, researchers are exploring innovative treatment approaches such as immunotherapy and biologic therapies that aim to reduce allergic sensitivity over time.

Future growth in the market is expected as awareness about food allergies continues to increase globally. Governments and healthcare organizations are promoting early diagnosis and improved management strategies to reduce allergy-related complications. Continuous research in allergy therapeutics and expanding healthcare services in emerging economies will likely support long-term market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Diagnostics
• Therapeutics

By Allergen Source

• Peanuts
• Milk
• Eggs
• Fish
• Shellfish
• Tree Nuts
• Wheat
• Soy
• Others

By End-use

• Hospitals And Clinics
• Academic Research Institutes
• Diagnostics Laboratories

COMPANIES PROFILED

• Astellas Pharma Inc, Aimmune Therapeutics, Meridian Medical Technologies, Medeca Pharma AB, bioMrieux SA, Omega Diagnostics Group PLC, Camallergy Cambridge Allergy Ltd, Immunomic Therapeutics Inc, Prota Therapeutics Pty Ltd, ALKAbell AS, HYCOR Biomedical, HOB Biotech Group Corp Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY ALLERGEN SOURCE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Allergen Source
• 5.2. Peanuts Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Milk Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Eggs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Fish Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Shellfish Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Tree Nuts Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Wheat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Soy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Allergen Source
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Allergen Source
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Allergen Source
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Allergen Source
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Allergen Source
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Astellas Pharma Inc
  • 9.2.2 Aimmune Therapeutics
  • 9.2.3 Meridian Medical Technologies
  • 9.2.4 Medeca Pharma AB
  • 9.2.5 BioMAfA(C)Rieux SA
  • 9.2.6 Omega Diagnostics Group PLC
  • 9.2.7 Camallergy (Cambridge Allergy Ltd)
  • 9.2.8 Immunomic Therapeutics Inc
  • 9.2.9 Prota Therapeutics Pty Ltd
  • 9.2.10 ALK-AbellAfA3 A/S
  • 9.2.11 HYCOR Biomedical
  • 9.2.12 HOB Biotech Group Corp. Ltd